Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, . . . Huseyin Naci. (2023). Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: A retrospective analysisResearch in context. Elsevier.
Chicago Style (17th ed.) CitationAdriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, and Huseyin Naci. Marketing Authorisation and Pricing of FDA-approved Cancer Drugs in Brazil: A Retrospective AnalysisResearch in Context. Elsevier, 2023.
MLA (9th ed.) CitationAdriana M. Ivama-Brummell, et al. Marketing Authorisation and Pricing of FDA-approved Cancer Drugs in Brazil: A Retrospective AnalysisResearch in Context. Elsevier, 2023.